Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conservatively managed non-functioning pituitary macroadenomas-cohort study from the UK Non-functioning Pituitary Adenoma Consortium.

European journal of endocrinology·2025
Same author

Susac syndrome: neurological update (clinical features, long-term observational follow-up and management of sixteen patients).

Journal of neurology·2023
Same author

Response of Recoverin-Positive Optic Neuritis to Chemotherapy, Steroid, and Plasma Exchange.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2023
Same author

Rathke's Cleft Cyst Abscess with a Very Unusual Course.

Asian journal of neurosurgery·2022
Same author

Endonasal endoscopic management of spontaneous cerebrospinal fluid rhinorrhoea: The Birmingham UK experience.

Asian journal of endoscopic surgery·2022
Same author

Foster Kennedy syndrome secondary to a giant prolactinoma with a remarkable response to cabergoline.

Endocrinology, diabetes & metabolism case reports·2022

Related Experiment Video

Updated: May 20, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control.

Ruchika Batra1, Rajen Tailor, Shabbir Mohamed

  • 1University Hospitals Birmingham, Birmingham, UK.

Journal of Glaucoma
|July 26, 2012
PubMed
Summary

Treating ocular surface disease (OSD) in patients with primary open angle glaucoma can improve intraocular pressure (IOP) control. This approach may help manage glaucoma refractive to standard medical therapy.

More Related Videos

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Ocular Surface Disease Management

Background:

  • Primary open angle glaucoma (POAG) management can be challenging in patients with co-existing ocular surface disease (OSD).
  • Severe OSD can render glaucoma medically refractory and compromise surgical outcomes.
  • The proposed condition, 'OSD exacerbated glaucoma,' highlights this complex interplay.

Purpose of the Study:

  • To describe a combination treatment approach for OSD in patients with inadequately controlled POAG.
  • To evaluate the impact of OSD management on intraocular pressure (IOP) control in these patients.

Main Methods:

  • Retrospective review of 4 patients with POAG and OSD.
  • Implemented combination OSD management: lid hygiene, oral doxycycline, topical carmellose sodium, and preservative-free glaucoma medications.
  • Patients were monitored for up to 24 months.

Main Results:

  • All patients showed significant symptomatic and clinical improvement in ocular surface health.
  • Observed reductions in ocular hyperemia, meibomian gland dysfunction, and superficial keratopathy.
  • Achieved a reduction in IOP in all patients, avoiding glaucoma drainage surgery.

Conclusions:

  • Aggressive management of OSD can improve IOP control in POAG patients.
  • Combination therapy for OSD is a viable strategy for 'OSD exacerbated glaucoma.'
  • This approach may enhance glaucoma management and reduce the need for further surgical intervention.